
Bioheaven 360 is a Delhi-based biotechnology startup recognized by the Inter-ministerial board, focusing on products and services in healthcare and life sciences. They specialize in molecular diagnostics, manufacturing testing kits, media, and reagents, with a strong emphasis on addressing communicable diseases such as TB, SARS, MERS, COVID-19, Dengue, malaria, and Chikungunya. The company leverages AI and deep learning for genomics applications in healthcare and is developing CRISPR-based diagnostics, therapeutics, and vaccines for cancer, cardiovascular diseases, and other communicable diseases. Bioheaven 360 aims to provide cost-effective, innovative solutions with wide applications, partnering with academic institutions and industry leaders.

Bioheaven 360 is a Delhi-based biotechnology startup recognized by the Inter-ministerial board, focusing on products and services in healthcare and life sciences. They specialize in molecular diagnostics, manufacturing testing kits, media, and reagents, with a strong emphasis on addressing communicable diseases such as TB, SARS, MERS, COVID-19, Dengue, malaria, and Chikungunya. The company leverages AI and deep learning for genomics applications in healthcare and is developing CRISPR-based diagnostics, therapeutics, and vaccines for cancer, cardiovascular diseases, and other communicable diseases. Bioheaven 360 aims to provide cost-effective, innovative solutions with wide applications, partnering with academic institutions and industry leaders.